Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-07-04
2006-07-04
Carlson, Karen Cochrane (Department: 1653)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C530S350000
Reexamination Certificate
active
07070940
ABSTRACT:
The present invention relates to a method for determining the ability of a compound to modify the interaction between parkin and the p38protein, and in particular to a method for screening for or detecting compounds intended for the prevention and/or treatment of neurodegenerative pathological conditions. The present inventions also relates to compounds identified in the above screening method.
REFERENCES:
patent: 5843757 (1998-12-01), Vogelstein et al.
patent: 6010856 (2000-01-01), Ulevitch et al.
patent: 6716621 (2004-04-01), Shimizu et al.
Cohen 1997; Trends in Cell Biology 7:353-361.
Abbas, Nacer et al., A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe, Human Molecular Genetics, (1999), vol. 8, No. 4, pp. 567-574.
Altschul Stephen F. et al., Basic Local Alignment Search Tool, Journal Molecular Biology, (1990), vol. 215, pp. 403-410.
Altschul Stephen F. et al., Gapped BLAST And PSI-BLAST: A New Generation Of Protein Database Search Programs, Nucleic Acids Research, (1997), vol. 25, No. 17, pp. 3389-3402.
C.B. Lucking et al., Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism, The Lancet, vol. 352, Oct. 24, 1998, pp. 1355-1356.
E. Leroy et al., The ubiquitin pathway in Parkinson's disease, Nature, vol. 395, Oct. 1, 1998, pp. 451-452.
E. Morett et al., A novel transactivation domain in parkin, Trends in Biochem Sci., vol. 24, Jun. 1999, pp. 229-231.
H. Shimura et al., Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase, Nature Genetics, vol. 25, Jul. 2000, pp. 302-305.
H. Shimura et al., Immunohistochemical and Subcellular Localization of Parkin Protein: Absence of Protein in Autosomal Recessive Juvenile Parkinsonism Patients, Ann. Neurol. vol. 45, 1999, pp. 668-672.
M. Polymeropoulos et al., Mutation in the alpha-synuclein gene identified in families with Parkinson's Disease, Science, vol. 276, Jun. 27, 1997, pp. 2045-2047.
N. Hattori et al., Molecular Genetic Analysis of a Novel Parkin Gene in Japanese Families with Autosomal Recessive Juvenile Parkinsonism: Evidence for Variable Homozygous Deletions in the Parkin Gene in Affected Individuals, Annals of Neurology, vol. 44, Issue 3, 1998, pp. 935-941.
R. Kopito, Aggresomes, inclusion bodies and protein aggregation, Trends in Cell Biology, vol. 10, Dec. 2000, pp. 524-530.
R.K. Brachmann et al., Tag games in yeast: the two-hybrid system and beyond, Current Opinion Biotechnol. vol. 8, No. 5, Oct. 1997, pp. 561-568.
S. Fields et al., A novel genetic system to detect protein—protein interactions, Nature, vol. 340, Jul. 20, 1989, pp. 245-246.
S. Quevillon et al., Macromolecular Assemblage of Aminoacyl-tRNA Synthetases: Identification of Protein-Protein Interactions and Characterization of a Core Protein, J. Mol. Biol. vol. 285, 1999, pp. 183-195.
Sanger et al., DNA sequencing with chain-terminating inhibitors, Proc. Natl. Acad. Sci. 74(12), 5463-5467 (1977).
T. Kitada et al., Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism, Nature, vol. 392, Apr. 9, 1998, pp. 605-608.
T.R. Flotte et al., Gene Expression from Adeno-associated Virus Vectors in Airway Epithelial Cells, Am. J. Respir. Cell Mol. Biol., vol. 7, 1992, pp. 349-356.
Y. Imai et al., Parkin Suppresses Unfolded Protein Stress-induced Cell Death through its E3 Ubiquitin-protein Ligase Activity, Journ. of Biol. Chem., vol. 275, No. 46, Nov. 17, 2000, pp. 35661-35664.
Y. Sunada et al., Differential expression of the parkin gene in the human brain and peripheral leukocytes, Neuroscience Letters, vol. 254, pp. 180-182.
Brice Alexis
Corti Olga
Fournier Alain
Hampe Cornelia
Pradier Laurent
Aventis Pharma S.A.
Carlson Karen Cochrane
Krupen Karen I.
LandOfFree
Method for determining the ability of a compound to modify... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for determining the ability of a compound to modify..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for determining the ability of a compound to modify... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3573329